Tanucan, Felipe B.
HRN: 21-91-84 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/24/2022
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
10/24/2022
10/31/2022
IV INFUSION
4.5g
Q8
Pulmonary Infection/ Infiltrates
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes